Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.
about
Phase IIb randomized trial of adjunct immunotherapy in patients with first-diagnosed tuberculosis, relapsed and multi-drug-resistant (MDR) TBAutophagy protects against active tuberculosis by suppressing bacterial burden and inflammationComplexity and Controversies over the Cytokine Profiles of T Helper Cell Subpopulations in TuberculosisRecent advances towards tuberculosis control: vaccines and biomarkersVaccines against tuberculosis: where are we and where do we need to go?Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosisBoosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosisT cell-mediated host immune defenses in the lungEfficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lungTh1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85ANovel vaccination strategies against tuberculosis.Toward novel vaccines against tuberculosis: current hopes and obstacles.CD4+ T cells contain early extrapulmonary tuberculosis (TB) dissemination and rapid TB progression and sustain multieffector functions of CD8+ T and CD3- lymphocytes: mechanisms of CD4+ T cell immunity.CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibitionDirecting traffic: IL-17 and IL-22 coordinate pulmonary immune defense.Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsEarly secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.The role of Th17 cytokines in primary mucosal immunityVariation of Mycobacterium tuberculosis antigen-specific IFN-γ and IL-17 responses in healthy tuberculin skin test (TST)-positive human subjects.Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection modelAgreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.IL-17 and Th17 cells in tuberculosisOrchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.Trachoma: protective and pathogenic ocular immune responses to Chlamydia trachomatis.IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection.B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response.TLR9 activation dampens the early inflammatory response to Paracoccidioides brasiliensis, impacting host survival.The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.Cytokine and lipid mediator networks in tuberculosisTranscriptional suppression of IL-27 production by Mycobacterium tuberculosis-activated p38 MAPK via inhibition of AP-1 binding.The frequencies of IFNγ+IL2+TNFα+ PPD-specific CD4+CD45RO+ T-cells correlate with the magnitude of the QuantiFERON® gold in-tube response in a prospective study of healthy indian adolescentsRecombinant BCG ΔureC hly+ induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responsesRegulation of neutrophils by interferon-γ limits lung inflammation during tuberculosis infection.Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients.Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.Impaired M. tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary TuberculosisOverexpression of RORγt Enhances Pulmonary Inflammation after Infection with Mycobacterium Avium.Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host
P2860
Q21245662-1504A184-1348-4948-9912-AB9997BE82E8Q24609294-5DF6BF04-9726-42DE-BD16-CECC730DD18AQ26779956-E9DE7C10-55E0-4FE4-8808-E53898C08066Q26859739-6B8FD082-1A68-462C-A132-D56C801287D9Q26992233-DDD0229C-A3FE-4AE1-8AD6-ECEC40BD9DF3Q27014743-805BBB60-4084-4CAE-828F-6F5440EBB9D9Q27315911-BF558E3F-4C0F-44A6-B437-485AFA685722Q28395374-9E9D8277-DC4A-41F2-9791-2EFEF26A2045Q28481571-534FCA6A-5F94-482D-829B-2E5F0E62212DQ28740954-2D2F42E0-6723-46FA-A70F-806BBAE90E35Q30363188-6E3074D7-8CDB-443B-9B91-09DCC8DF438DQ30484783-6503D94A-3363-4850-8B70-5358398B5E52Q30584398-E6E51E2E-C1A5-4BBF-9792-87AB123CF67DQ33762255-B4802E4F-AE68-44F6-967A-01F3E2B0272CQ33788735-D2D38622-69B0-43DA-9A09-0B39D4D7EBC5Q33809045-0F65A721-CF9A-4D91-83B5-C9F613A9DAA6Q34079170-95372D62-FF58-401D-A719-FFD569817E9BQ34151076-7D044AA9-FB36-4D20-AA9E-C77DFEAB3719Q34374644-BEFB6A7E-555F-47C0-A4E6-260FD77FBD67Q34460946-8B2AF40E-74C9-4F58-ACDE-462026F7424AQ34486077-5FC6B3FD-A58E-4512-B974-7FA3D9D35C50Q34513982-BABB0ECA-B9E5-403A-861F-C2F088BEC998Q34545889-5719C481-D1CE-4301-87A4-21F09AFAF527Q34603687-86E6D106-E92F-4F54-B051-9CD110A3A2FDQ34607259-706F641F-17BA-4BFF-825E-4B8EB6628C14Q34608524-1B15CF42-82AB-4CAF-AF6D-0FFF7D426A81Q34819635-1BC2FA3C-6838-4B87-91BF-C569FB67A5E6Q34927375-3D9A5EC8-1F9B-48F2-B8BD-D79E81C4F649Q34983762-DCCF9E53-8CAD-4248-8FBB-0D3E7E3835A7Q35117086-7AE53AE5-C65A-4F9A-A20F-61915AAAF57EQ35148364-4243FA29-98BE-4F59-9E7A-30EAB2E47844Q35200725-9BDF1068-6E11-4ECA-9191-A541BDCDBA1CQ35331449-900D612F-C6F8-4523-A061-0B43A2BC3FBFQ35441389-5911DE2E-28C5-468E-934D-31FD5C0B8E83Q35594683-FB222403-4781-4069-B1C9-27D70EA90A9CQ35599219-90ABFE0B-FE8A-4C71-8C32-39AE4F6E9DF2Q35643237-C8A69655-9CF0-4EFA-9270-510FE7E71376Q35643864-6B8A9E48-BA62-4ABC-82F0-3DD2384816C3Q35897823-4472E7BD-8636-4F40-BD98-16A3D54AEBD5Q35913538-B3510D93-7B5F-44C3-9AB0-F5A2A8D0E180
P2860
Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@ast
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@en
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@nl
type
label
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@ast
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@en
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@nl
prefLabel
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@ast
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@en
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@nl
P2093
P2860
P50
P356
P1476
Pathological role of interleuk ...... th Mycobacterium tuberculosis.
@en
P2093
Daniela R Pereira
Jeffrey J Fountain
Troy D Randall
P2860
P304
P356
10.1084/JEM.20100265
P407
P50
P577
2010-07-12T00:00:00Z